Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Biomarker profiles for predicting outcomes of cancer therapy with ERBB3 inhibitors and/or chemotherapies

Biomarker profiles for predicting outcomes of cancer therapy with ERBB3 inhibitors and/or chemotherapies

US Patent 10273304 · Granted Apr 30, 2019

Estimated economic value: $1,319,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Squeeze-type electrode connector2025
Delivery of biomolecules to PBMCs to modify an immune response2023
Nanoliposomal irinotecan for use in treating small cell lung cancer2022
Double-power-supply switching control system for a welding machine and method2021
Display screen or portion thereof with graphical user interface2019
Biomarkers for predicting outcomes of cancer therapy with ErbB3 inhibitors2019
Biomarkers for predicting outcomes of cancer therapy with ErbB3 inhibitors2019
Method for lysing a single cell in a solid tissue2018
Frizzled 2 as a target for therapeutic antibodies in the treatment of cancer2017
Biomarker profiles for predicting outcomes of cancer therapy with ERBB3 inhibito2017
Biomarker profiles for predicting outcomes of cancer therapy with ERBB3 inhibito2017
Biomarker profiles for predicting outcomes of cancer therapy with ERBB3 inhibito2017